S81198 |
AT406 (SM-406) |
源葉(MedMol) | 98% |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述: Xevinapant (AT-406) is a potent and orally bioavailable Smac mimetic and an antagonist of IAPs, and it binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, respectively.
- 靶點: cIAP1:1.9 nM (Ki);cIAP2:5.1 nM (Ki);XIAP:66.4 nM (Ki);IAP
- 體內(nèi)研究:
Xevinapant (AT-406) is very effective in inhibition of tumor growth in the MDA-MB-231 xenograft model, and has minimal toxicity to animals.Xevinapant is evaluated for its pharmacokinetic (PK) properties in mice, rats, non-human primates and dogs.
- 參考文獻:
1. Cai Q, Sun H, Peng Y, et al. A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J Med Chem. 2011;54(8):2714-2726.
- 溶解性: DMSO : 100 mg/mL (178.03 mM; Need ultrasonic)
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.78 ml 8.901 ml 17.803 ml 5 mM 0.356 ml 1.78 ml 3.561 ml 10 mM 0.178 ml 0.89 ml 1.78 ml 50 mM 0.036 ml 0.178 ml 0.356 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)